Browsing HLS Student Papers by Title
Now showing items 120-139 of 498
-
English is not Enough: The Language of Food and Drug Labels
(2002)Food and drug labels must respond to the needs of the increasing linguistic minority population in the United States. Currently, the FDA only requires that food and drug labels be in English. Due to the growing segment of ... -
Ensuring a Consistent Supply of Anthrax Vaccine
(2002)During the recent anthrax attacks, the country's supply of anthrax vaccine was dangerously low. The reasons for this were (1) the failure of the FDA, the Defense Department, and its contractor, BioPort Corporation, to plan ... -
Ephedra and the FDA
(2001)The adverse events experienced after ingesting ephedra and other dietary supplements have demonstrated the need for FDA intervention. The FDA has an important role to play in safeguarding the health and safety of the ... -
Equitable Division of International Joint Costs in Pharmaceutical Research and Development
(2004)Significant increases in pharmaceutical spending over the past two decades have lead to public outrage over the cost of prescription drugs. Pharmaceutical research and development is an expensive process – ... -
Establishing a No-Fault Compensation System to Replace Failure-to-Warn Product Liability Claims Against Prescription Drug Manufacturers
(2014-03-18)In 1986, Congress passed the National Childhood Vaccine Injury Act, which established a no-fault compensation system to provide money to people who are injured by vaccines. The major impetus behind this Act was the soaring ... -
Estimating Inequality with Tax Data: The Problem of Pass-Through Income
(2015)In recent decades, a growing share of U.S. business income has been taxed on a pass-through basis. When taxed on a pass-through basis, business income is attributed to a firm’s owners and taxed to them as individual income, ... -
The Ethical and Regulatory Problems in the Stem Cell Scandal
(2006)The recent stem cell scandal of fabrication of two papers published in Science by Dr. Hwang Woo Suk shocked the world and devastated the South Korean society. Investigations conducted by the South Korean government have ... -
An Evaluation of the Legal Responses to America's Obesity Epidemic
(2004)This paper will examine the recent legal action surrounding one of America's major public health problems; obesity. The discussion begins with a quick presentation of information regarding our nation's obesity epidemic. ... -
Evergreening: A Common Practice to Protect New Drugs
(2011)Exclusivity periods serve as an incentive for pharmaceutical companies to engage in the costly and risky activities underlying drug discovery and development. Patents offer one form of exclusivity. Other exclusivities are ... -
The Evolution and Future of the Medicare Chemotherapy Concession
(2004)Cancer is a life threatening disease that affects thousands of Americans each year. Chemotherapy is one of the most effective treatments for the disease, but its prohibitive cost makes it all but unavailable to those without ... -
The Evolution of the Modern Snack Tax Bill: From World War I to the War Against Obesity
(2006)This paper offers a historical perspective on soft drinks and snack taxes in the United States in light of recent legislative snack tax proposals that have been introduced in at least twenty states since an obesity crisis ... -
The Evolving Regulation of Internet Pharmacies
(2014-03-18)This paper follows the rise of the Internet drug sale industry and the response to the trend by regulators, policymakers, and private companies. After discussing the existing laws and their enforcement to police rogue ... -
An Examination of Strict Criminal Liability Under the Food, Drug and Cosmetic Act of 1938: Is It Time For Change?
(1999)Food and drug violations have been largely governed by a strict liability standard since the nineteenth century. Use of this standard in connection with criminal sanctions has generally been defended on the grounds that ... -
The Expansion of FDA's Enforcement Powers from 1906-2003
(2003)This paper discusses the history of the FDA with a focus on the expansion of FDA regulatory powers. -
Expediting Oncology Drug Approvals: The Public Backlash Against the FDA and Opportunities to Reform
(2005)The FDA has made great strides over the past twenty years in loosening drug approval regulations to speed important, life-saving treatments to market. However, recent controversies involving anti-depressants for children ... -
An Extraterritorial FDA: Could the Food and Drug Administration Apply Its Informed Consent Requirement Abroad Consistent with International Law?
(2012)This paper addresses the regulatory challenges wrought by the increasing amount of human subject drug testing conducted in developing countries in support of new drug applications to the Food and Drug Administration. ... -
Fact or Fiction? The MSG Controversy
(2005)Monosodium glutamate (“MSGâ€) has become one of the most well-known and controversial food ingredients in recent history. Linked to the “Chinese Restaurant Syndrome,†... -
The FDA & The FTC: An Alphabet Soup Regulating The Misbranding Of Food
(2002)This paper will first look at the historical development of the division of regulation of food labeling by the Food and Drug Administration (FDA) and the regulation by food advertising by the Federal Trade Commission (FTC). ... -
THE FDA AND PLAN B: The Legislative History of the Durham-Humphrey Amendments and the Consideration of Social Harms in the Rx-OTC Switch
(2006)The 1951 Durham-Humphrey Amendments limited the FDA’s power over the Rx-OTC decision by enacting an objective definition of a prescription drug that would be applied primarily by drug manufacturers. Under ... -
FDA and Social Media: The Impact of Social Media on Prescription Drug Advertising
(2011)The U.S. Food and Drug Administration (FDA) regulates the promotion of prescription drugs. With the emergence of Web 2.0 technology and social media, the FDA faces new regulatory challenges as pharmaceutical companies have ...